COHANCE LIFESCIENCES LTD (COHANCE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling cus…
Cohance Lifesciences Ltd
COHANCE
ROE7.36%
ROCE10.4%
Stock P/E68.1
Book Value₹117
Face Value₹1.00
High / Low₹1,079/267
Market Cap₹17,045Cr.
Current Price₹446
Dividend Yield0.00%
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 22 July 2026 at 1:51:49